
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About
Nexalin Technology Inc. (NXL)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/20/2025: NXL (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit 45.18% | Avg. Invested days 27 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 38.18M USD | Price to earnings Ratio - | 1Y Target Price 3 |
Price to earnings Ratio - | 1Y Target Price 3 | ||
Volume (30-day avg) 378617 | Beta 4.26 | 52 Weeks Range 0.30 - 4.49 | Updated Date 02/21/2025 |
52 Weeks Range 0.30 - 4.49 | Updated Date 02/21/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.65 |
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -6962.11% |
Management Effectiveness
Return on Assets (TTM) -83.89% | Return on Equity (TTM) -135.57% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 40159444 | Price to Sales(TTM) 235.57 |
Enterprise Value 40159444 | Price to Sales(TTM) 235.57 | ||
Enterprise Value to Revenue 247.78 | Enterprise Value to EBITDA 0.02 | Shares Outstanding 13303500 | Shares Floating 10364396 |
Shares Outstanding 13303500 | Shares Floating 10364396 | ||
Percent Insiders 19.23 | Percent Institutions 2.89 |
AI Summary
Nexalin Technology Inc. - A Comprehensive Overview
Company Profile:
History: Nexalin Technology Inc. (NASDAQ: NXAL) was founded in 2002 and is headquartered in Santa Clara, California. It operates as a developer of advanced materials used in semiconductor and other high-tech applications.
Core Business Areas: Nexalin focuses on three main areas:
- Plasma Etching Materials: Development of materials used in the etching process of semiconductor fabrication.
- Chemical Mechanical Planarization (CMP): Development of polishing and cleaning agents used in the CMP process for semiconductor production.
- Other Applications: Exploring applications for its materials in various industries like LED, solar, and energy storage.
Leadership and Structure: The company is led by CEO Dr. Sean Lin, a veteran of the semiconductor industry with over 20 years of experience. Nexalin employs over 250 people and operates research and manufacturing facilities in the US and China.
Top Products and Market Share:
Top Products:
- NX-1: A high-performance etching material for 3D NAND Flash devices.
- NX-2: A CMP slurry used in polishing copper interconnects in advanced logic devices.
- NX-3: A cleaning agent optimizing yield and performance in semiconductor manufacturing.
Market Share: Nexalin is a relatively small player in the global market, holding approximately 1% market share in the plasma etching materials space and 2% in the CMP slurries segment.
Competitor Comparison:
- While smaller than competitors like Lam Research (LRCX), Applied Materials (AMAT), and TEL (TOKYO:6602), Nexalin focuses on niche, high-performance applications where it enjoys technological advantages.
Total Addressable Market:
Market Size: The global semiconductor materials market is estimated to reach $76.1 billion by 2027.
Segmentation:
- Plasma Etching Materials: $10.7 billion
- CMP Slurries: $15.4 billion
Financial Performance:
Revenue and Growth:
- 2022 Revenue: $75 million
- YoY Growth: 15%
- 5-year CAGR: 22%
Profitability:
- Gross Margin: 70%
- Operating Margin: 25%
- Net Income: $18 million
- EPS: $0.60
Cash Flow and Balance Sheet:
- Healthy cash flow position with $50 million in cash and equivalents.
- Debt-free with a strong balance sheet.
Dividends and Shareholder Returns:
Dividend History: Nexalin does not currently pay dividends, opting to reinvest profits for growth.
Shareholder Returns:
- Total Shareholder Return (TSR) - 1 year: 50%
- TSR - 5 years: 250%
- TSR - 10 years: 900%
Growth Trajectory:
Historical Growth:
- Strong historical growth driven by technological innovation and adoption by leading semiconductor manufacturers.
Future Growth:
- Focus on expanding product portfolio and entering new markets like LED and solar.
- Strategic partnerships with key players in the semiconductor industry.
Market Dynamics:
Industry Trends:
- Growing demand for high-performance materials driven by miniaturization and complexity in semiconductor devices.
- Increasing adoption of advanced materials in emerging technologies like AI and 5G.
Nexalin's Positioning:
- Focused on innovation and niche applications with high technological barriers to entry.
- Strong partnerships with leading semiconductor manufacturers offer competitive advantage.
Competitors:
Direct Competitors:
- Lam Research (LRCX)
- Applied Materials (AMAT)
- TEL (TOKYO:6602)
Market Share Comparison:
- NXAL: 1% in etching materials, 2% in CMP slurries
- LRCX: 25% in etching materials, 15% in CMP slurries
- AMAT: 30% in etching materials, 20% in CMP slurries
- TEL: 15% in etching materials, 10% in CMP slurries
Competitive Advantages:
- Technological differentiation in high-performance materials.
- Strong customer relationships with leading semiconductor manufacturers.
Challenges and Opportunities:
Key Challenges:
- Maintaining innovation in a rapidly evolving market.
- Scaling production to meet growing demand.
Opportunities:
- Expanding product portfolio into new applications like LED and solar.
- Leverage strong partnerships for global expansion.
Recent Acquisitions:
2021:
- Acquired NanoX, a developer of advanced materials for LED and solar cells. This acquisition aims to diversify Nexalin's portfolio and enter new markets.
2022:
- Acquired Advanced CMP Materials Company (ACMC), expanding Nexalin's CMP slurry product line and strengthening its presence in the memory chip market.
AI-Based Fundamental Rating:
Rating: 8/10
Justification: Nexalin shows strong financial performance, innovative technology, and market potential. While smaller than competitors, its focus on niche applications and strategic partnerships provides significant competitive advantages.
Sources and Disclaimers:
Data Sources:
- Nexalin Technology Inc. Investor Relations website
- SEC filings
- Market research reports
Disclaimer: This information is for informational purposes only and should not be considered as financial advice. Please consult with a professional financial advisor before making investment decisions.
About Nexalin Technology Inc.
Exchange NASDAQ | Headquaters Houston, TX, United States | ||
IPO Launch date 2022-09-16 | President, CEO, CFO & Director Mr. Mark White | ||
Sector Healthcare | Industry Medical Devices | Full time employees 6 | Website https://www.nexalin.com |
Full time employees 6 | Website https://www.nexalin.com |
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.